Browse News
Filter News
Found 101 articles
-
Genetic Analysis Market Size to Attain Around USD 23.60 BN by 2033
3/28/2024
The global genetic analysis market was evaluated at USD 10.55 billion in 2023 and is expected to attain around USD 23.60 billion by 2033
-
ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights
11/14/2023
ProMIS Neurosciences Inc. (Nasdaq: PMN) today announced financial results for the third quarter ended September 30, 2023 and provided a corporate update.
-
Cayman Chemical Receives CEP for Latanoprost API from EDQM
9/19/2023
Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients
-
Abata Therapeutics Announces Second Development Candidate, ABA-201, a Novel Treg Cell Therapy for the Treatment of Type 1 Diabetes
8/24/2023
Abata Therapeutics today announced its second development candidate, ABA-201, which has the potential to be a disease-modifying Treg cell therapy for patients with type 1 diabetes (T1D) who have remaining beta (β) cell function.
-
Data Published in JCEM Demonstrate Strong Real-World Performance of Veracyte’s Afirma GSC in Thyroid Cancer Diagnosis
12/15/2022
Veracyte, Inc. announced that findings demonstrating the strong real-world performance of the Afirma Genomic Sequencing Classifier were published in The Journal of Clinical Endocrinology & Metabolism.
-
Retinal Disorder Treatment Market Size Share Growth Trends Consumption Revenue Company Analysis And Forecast 2023 - 2032
12/13/2022
According to Vision research Reports, the global retinal disorder treatment market size surpassed at US$ 11.78 Billion in 2022 and to reach US$ 25.91 billion by 2032 with a CAGR of 9.48% from 2023 to 2032.
-
Cardiac Resynchronization Therapy Market Size to Hit US$ 10.8 BN by 2030
11/30/2022
The global cardiac resynchronization therapy market size was valued at USD 4.85 billion in 2020, and is predicted to be worth around USD 10.8 billion by 2030, registering a CAGR of 7.2% during the forecast period 2022 to 2030.
-
Benign Prostatic Hyperplasia Treatment Market Size to Gain USD 12.9 BN by 2030
11/21/2022
According to Nova one advisor, the global Benign Prostatic Hyperplasia Treatment market was valued at USD 6.48 billion in 2021 and it is expected to hit around USD 12.9 billion by 2030 with a CAGR of 5.68% during the forecast period 2022 to 2030.
-
Antibody Drugs Market Size USD 1.2 BN by 2030 With a CAGR of 4.8%
11/16/2022
According to Nova one advisor, the global Antibody Drugs market was valued at USD 560.7 million in 2021 and it is expected to hit around USD 1.2 billion by 2030 with a CAGR of 4.8% during the forecast period 2022 to 2030.
-
Alcoholic Hepatitis Therapeutics Market Size, Share, Growth, Forecast Report 2022-2030
11/8/2022
According to Latest Report Study, the global alcoholic hepatitis therapeutics market size was valued at US$ 0.7 billion in 2021 and is expected to reach US$ 1.3 billion by 2030 expanding at a CAGR of 6% from 2022 to 2030.
-
Saint Louis University Launches New Institute to Advance Neuroscience Research
11/3/2022
On Wednesday, Nov. 2, Saint Louis University announced the launch of the Institute for Translational Neuroscience.
-
Hyperthermia Cancer Treatment Market Size to Reach US$ 265 Million by 2030
10/4/2022
The global hyperthermia cancer treatment market size is expected to reach US$ 265 million by 2030 from US$ 160 million in 2020, growing at a CAGR of 5.8% from 2021 to 2030.
-
Drug Repurposing Market Demand and Growth Analysis with Forecast up to 2026
9/16/2022
Drug repurposing, also known as drug re-profiling or drug re-positioning, refers to research regarding a biologic agent or a compound that can effectively treat one condition to see whether it can safely and effectively treat other health conditions or diseases.
-
Acute Kidney Injury Therapeutics Market Competitive Research and Precise Outlook 2018 to 2026
9/13/2022
Acute kidney injury can be described as partial or full loss of kidney function because of sudden damage to the organ.
-
Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
9/1/2022
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant molecular diagnostic tests and pathology services for improved patient diagnosis and management, today announced new clinical validation data for their thyroid cancer test platform which is comprised of a mutation panel (ThyGeNEXT®) and a microRNA (miRNA) risk classifier.
-
Brain Mapping Instruments Market: Rise in Prevalence of Neurological Disorders in the Geriatric Population to Propel the Market
8/26/2022
Wilmington, Delaware, United States, Transparency Market Research Inc. – Brain mapping is an integral part of contemporary neurosurgery.
-
Immunotherapy Drugs Market Size to Exhibit USD 200.62 Bn by 2030
8/22/2022
According to Vision Research Reports, the global immunotherapy drugs market was estimated at USD 110.74 billion in 2021 and it is expected to surpass around USD 200.62 billion by 2030, poised to grow at a CAGR of 6.83% from 2022 to 2030
-
Clinical Alarm Management Market: Rise in Prevalence of Chronic Diseases to Drive the Market
8/17/2022
Wilmington, Delaware, United States, Transparency Market Research Inc. – Clinical alarms are used to warn caregivers of potential adverse or immediate patient conditions.
-
Non-Alcoholic Steatohepatitis Treatment Market Size, Report 2022-2030
8/11/2022
The global non-alcoholic steatohepatitis (NASH) treatment market was valued at USD 1.1 billion in 2021 and it is predicted to surpass around USD 16.3 billion by 2030 with a CAGR of 34.92% from 2022 to 2030
-
Cell and Gene Therapy Market Size, Growth, Trends, Forecast Report 2022-2030
8/11/2022
According to Vision Research Reports, the global cell and gene therapy market size is expected to hit around USD 42.56 billion by 2030, growing at a CAGR of 39.42 % during the forecast period 2022 to 2030.